Wilson-Thompson Kathleen

Tesla director Kathleen Wilson-Thompson exercises options, then liquidates nearly all shares same day in systematic pattern.

Director Kathleen Wilson-Thompson exercised a large option grant and immediately sold nearly all shares acquired in a single-day multi-tranche liquidation. This is a classic tax-efficient exercise-and-sell pattern—common when directors receive options as compensation and need cash or want to reduce concentration risk. The systematic nature of the sale (17 tranches at progressively higher prices) suggests algorithmic execution rather than reactive decision-making. While the overall transaction volume exceeded routine thresholds, the structure itself—acquiring shares only to sell them same-day—carries no signal of insider confidence in Tesla's direction. The company remains profitable but faces revenue pressure year-over-year, and the stock is trading well below its recent highs, yet this director's behavior reflects compensation liquidity management, not a conviction bet on the business.

Director Kathleen Wilson-Thompson sold 25,809 shares of TSLA for $9,273,888.39 on 2026-03-30 via 10b5-1 plan.

Director Kathleen Wilson-Thompson executed 15 separate sales totaling 25,809 shares for $9,273,888.39 at prices ranging from $352.83 to $366.86, reducing her holdings by 43.3% from 59,669 shares to 33,860 shares. The transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-11-26, indicating these sales were scheduled and not discretionary decisions made in response to current market conditions. The staggered pricing across multiple tranches reflects the mechanics of a programmatic plan rather than a single point-in-time judgment. Directors retain substantial holdings post-transaction, maintaining meaningful equity alignment with shareholders.

Director Kathleen Wilson-Thompson sold 25,731 shares for $10,692,813.53 under pre-arranged 10b5-1 plan adopted 2025-11-26

Kathleen Wilson-Thompson, a Tesla director, executed 7 separate sales totaling 25,731 shares for $10,692,813.53 on 2026-02-25 at prices ranging from $412.46 to $418.89, with a blended average price of $415.56. This sale reduced her holdings by 56.7%, from 45,400 shares to 19,669 shares post-transaction. The transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-11-26, meaning the sales were scheduled and not discretionary. As a Rule 10b5-1 plan-directed transaction, this sale is not indicative of contemporaneous insider conviction or concern; rather, it reflects an automated execution of a predetermined schedule established months in advance.

Director Kathleen Wilson-Thompson sold 100,000 shares for $41.2M via scheduled 10b5-1 plan adopted 2024-08-12

Director Kathleen Wilson-Thompson executed 23 separate sales on 2025-01-06 totaling 100,000 shares (100.0K shares) for $41,162,798.62 ($41.2M) at prices ranging from $402.84 to $426.14, reducing her holdings by 94.9% from 105,400 shares (105.4K shares) to 5,400 shares (5.4K shares). This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2024-08-12, making it a scheduled, non-discretionary execution rather than a discretionary sell decision. The large-scale divestiture substantially reduces her direct equity stake in the company while remaining within the mechanics of a previously-established plan.

Tesla Director Kathleen Wilson-Thompson sold 100,000 shares for $35.3M across 10 transactions on 2024-12-04 via pre-arranged 10b5-1 plan

Director Kathleen Wilson-Thompson executed 10 separate sales totaling 100,000 shares for $35,253,875.28 on 2024-12-04, reducing her stake from 105,400 shares to 5,400 shares post-transaction. This represents a -94.9% reduction in her holdings. The transaction was executed under a pre-arranged 10b5-1 trading plan adopted on 2024-08-12, meaning the sales were scheduled in advance rather than discretionary. The blended average sale price across all 10 transactions was $352.54 per share, with individual transaction prices ranging from $349.20 to $357.93. The substantial concentration of shares sold—nearly her entire position—warrants investor attention regarding director-level confidence signals and future board representation.

Director Kathleen Wilson-Thompson sells 100,000 shares for $34.6M via pre-arranged 10b5-1 plan on 2024-11-11, reducing holdings 94.9%.

Director Kathleen Wilson-Thompson executed 22 separate sales totaling 100,000 shares for $34,602,453.93 on 2024-11-11 under a pre-arranged 10b5-1 trading plan adopted on 2024-08-12. This transaction reduced her holdings from 105,400 shares to 5,400 shares—a net change of sold 100,000 shares (-94.9% vs pre-transaction holdings). The blended average price across all 22 sales was $346.02. Since the transaction is part of a scheduled 10b5-1 plan rather than discretionary, timing reflects the plan's mechanics, not market judgment at execution. The near-complete liquidation of her Tesla position warrants investor attention as a significant reduction in insider equity exposure.